Skip to main content
Gulf Pharmaceutical Industries logo

Gulf Pharmaceutical Industries — Investor Relations & Filings

Ticker · JULPHAR ISIN · AEG000201018 Abu Dhabi Securities Exchange Manufacturing
Open in API
Filings indexed 360 across all filing types
Latest filing 2021-05-08 Regulatory Filings
Country AE United Arab Emirates
Listing Abu Dhabi Securities Exchange JULPHAR

About Gulf Pharmaceutical Industries

https://www.Julphar.net

Gulf Pharmaceutical Industries (Julphar) is a prominent pharmaceutical manufacturer and distributor. The company specializes in producing a diverse portfolio of medicines, vaccines, and consumer healthcare products, addressing a broad spectrum of health conditions. Julphar is recognized as one of the largest generic pharmaceutical manufacturers in the Middle East and North Africa, and a leading global producer of insulin. Utilizing internationally accredited, state-of-the-art facilities, it manufactures over one million medicine boxes daily, distributing products to more than 40 countries. The company's operations emphasize high quality and safety standards in its comprehensive manufacturing capabilities.

Recent filings

Filing Released Lang Actions
Gulf Pharmaceutical Industries Announcements
Regulatory Filings
2021-05-08 English
وقف التداول موقتا علي أسهم شركة شركة الخليج للصناعات الدوائية
Regulatory Filings Classification · 95% confidence The document is a resolution concerning the temporary suspension of trading on the shares of Gulf Pharmaceutical Industries. It references a specific date and time for suspension related to a board meeting and trading session at ADX (Abu Dhabi Securities Exchange). The content is regulatory in nature, announcing a trading halt rather than providing financial data, management discussion, or detailed report content. The document is short (1819 characters) and serves as an official announcement of a regulatory action. It does not contain financial statements, audit information, or meeting materials. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements that do not fit other specific categories.
2021-05-05 Arabic
Temporary suspension of trading on the shares of Gulf Pharmaceutical Industries
Regulatory Filings Classification · 95% confidence The document is a resolution concerning the temporary suspension of trading on the shares of Gulf Pharmaceutical Industries. It references a specific date and time for the suspension related to a board meeting and trading session. The content is an official announcement about trading suspension, not a financial report, earnings release, or management discussion. It is regulatory in nature, related to stock exchange operations and compliance, but does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is not a report publication announcement since it does not mention any report being published or attached. The document is best classified as a Regulatory Filing (RNS) because it is a formal regulatory announcement about trading suspension on the exchange.
2021-05-05 English
شركة الخليج للصناعات الدوائية محضر اجتماع جمعية عمومية المنعقد بتاريخ 18/04/2021 الساعة 13:00
Regulatory Filings
2021-05-03 Arabic
Gulf Pharmaceutical Industries AGM Minutes held on 18/04/2021 at 13:00
Regulatory Filings
2021-05-03 English
شركة الخليج للصناعات الدوائية اعلان اجتماع مجلس الإدارة بتاريخ 09/05/2021 الساعة 11:00
Regulatory Filings
2021-05-03 Arabic

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.